Drug · DIN 02237009
ZERIT
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since November 14, 2017.
- Drug Identification Number (DIN)
- 02237009
- Company (DIN owner)
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Oral
- Therapeutic class (ATC)
- Stavudine J05AF04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| STAVUDINE | 1 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 15, 1997: NOC 4092Supplement to a New Drug Submission (SNDS) · Provides for new dosage form and new pediatric indication